Concepedia

Iurie Moscalu

IM

8

Publications

443

Citations

8

H-Index

2017

Active since

Affiliations

Nicolae Testemițanu State University of Medicine and Pharmacy(Current)

University of Duisburg-Essen

Abbott Fund

Iurie Moscalu is an author at Nicolae Testemițanu State University of Medicine and Pharmacy specializing in viral hepatitis, hepatitis, and medicine.

Top concepts

Publications per year

2017–2022

8

Publications

8

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

Michel Bazinet, Victor Pântea, Gheorghe Plăcintă et al. · Gastroenterology · 2020 · 218 citations · Full text

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

Fabien Zoulim, Oliver Lenz, Joris Vandenbossche et al. · Gastroenterology · 2020 · 114 citations · Full text

Safety, pharmakokinetics and antiviral activity of novel capsid assembly modulator (CAM) JNJ-56136379 (JNJ-6379) in treatmentnaive chronic hepatitis B (CHB) patients without cirrhosis

Fabien Zoulim, Jeysen Yogaratnam, Joris Vandenbossche et al. · Journal of Hepatology · 2018 · 25 citations

, , +11

Update on safety and efficacy in the REP 401 protocol: REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infection

Michel Bazinet, Victor Pântea, Gheorghe Plăcintă et al. · Journal of Hepatology · 2017 · 21 citations

, , +8

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy

Michel Bazinet, Mark Anderson, Victor Pântea et al. · Hepatology Communications · 2021 · 20 citations · Full text

Rows per page

1–5 of 8